A gene therapy being developed by RegenX Bio of Rockville, MD, showed early promise against wet macular degeneration, a leading cause of blindness.
RegenXBio Gene Therapy Shows Early Promise Eye Disease; Cholesterol Treatment Results Mixed
A gene therapy being developed by RegenX Bio of Rockville, MD, showed early promise against wet macular degeneration, a leading cause of blindness.